Edwards Lifesciences Corp. (EW) reported third quarter EPS of $0.68 after the bell Tuesday, compared to $0.54 in the prior year. The results matched analysts' expectations. The company expects to report fourth quarter EPS of $0.67 to $0.77. The consensus estimate is for EPS of $0.74.
from RTT - Before the Bell http://ift.tt/2dOtCv6
via IFTTT
No comments:
Post a Comment